Her-2 Neu Expression in Endometrial Carcinoma

Prognostic and Predictive Significance of EpCAM and SOX2 expression in Serous Ovarian Carcinoma

P53 EXPRESSION AS A RISK FACTOR IN TYPE 1 ENDOMETRIAL CANCER

Immunohistochemical Study of PDL-1 Expression in Urinary Bladder Carcinoma

Expression of Her-2/neu in endometrial carcinoma and its relation with clinicopathological variables

IMMUNOHISTOCHEMICAL EXPRESSION OF ESTROGEN RECEPTORS AS PROGNOSTIC MARKER AND CORRELATION WITH CLINICOPATHOLOGICAL PARAMETERS IN HUMAN ENDOMETRIAL ADENOCARCINOMA

Stratification of Endometrial Carcinoma Patients Using Immunohistochemistry for Better Surgical Planning and Prognosis

The Diagnostic and Prognostic Significance of ARID1A and CD8+ Expression in Endometrial Hyperplasia and Endometrial Endometrioid Adenocarcinoma (Immunohistochemical study)

The prognostic significance of Minichromosome maintenance protein 2 (MCM2) and Trans-glutaminase 2 (TGM2) in Endometrial carcinoma: immunohistochemical and serological study

Validity of CA-125 in the Diagnosis of Absent Lymph Node Metastasis in Endometrial Cancer Patients